MNPR · Monopar Therapeutics · Documents
Market Cap
$727.06M
Shares
6.71M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 10-Q | 2026-08-12 | 2026-06-30 | |
| 8-K | 2026-08-12 | — | |
| 8-K | 2026-07-22 | — | |
| 8-K | 2026-06-30 | — | |
| 8-K | 2026-06-26 | — | |
| 8-K | 2026-06-23 | 2026-06-22 | |
| 8-K | 2026-05-29 | — | |
| 8-K | 2026-05-19 | — | |
| 8-K | 2026-05-14 | — | |
| 10-Q | 2026-05-14 | 2026-03-31 | |
| DEF 14A | 2026-04-30 | 2026-06-22 | |
| 8-K | 2026-04-20 | 2026-04-19 | |
| 10-K/A | 2026-04-01 | 2025-12-31 | |
| 10-K | 2026-03-27 | 2025-12-31 | |
| 8-K | 2026-03-27 | — | |
| 8-K | 2026-03-02 | — | |
| 10-Q | 2025-11-13 | 2025-09-30 | |
| 8-K | 2025-11-13 | — | |
| 8-K | 2025-11-10 | 2025-11-09 | |
| 8-K | 2025-09-24 | 2025-09-23 | |
| 8-K | 2025-09-15 | — | |
| 10-Q | 2025-08-12 | 2025-06-30 | |
| 8-K | 2025-08-12 | — | |
| 8-K | 2025-06-23 | 2025-06-17 | |
| 10-Q | 2025-05-13 | 2025-03-31 | |
| 8-K | 2025-05-13 | — | |
| 8-K | 2025-05-07 | — | |
| DEF 14A | 2025-04-30 | 2025-06-17 | |
| 10-K | 2025-03-31 | 2024-12-31 | |
| 8-K | 2025-03-31 | — | |
| 8-K | 2025-03-03 | 2025-02-27 | |
| 8-K | 2025-02-24 | 2025-02-19 | |
| 8-K | 2024-12-23 | 2024-12-20 | |
| 8-K | 2024-12-06 | — | |
| 8-K | 2024-11-08 | — | |
| 10-Q | 2024-11-08 | 2024-09-30 | |
| 8-K | 2024-10-30 | 2024-10-28 | |
| 8-K | 2024-10-24 | 2024-10-23 | |
| 8-K | 2024-10-22 | — | |
| 8-K | 2024-10-15 | — | |
| 8-K | 2024-10-07 | — | |
| 8-K | 2024-09-12 | — | |
| 8-K | 2024-08-27 | — | |
| 8-K | 2024-08-21 | — | |
| 8-K | 2024-08-14 | — | |
| 8-K | 2024-08-09 | — | |
| 10-Q | 2024-08-09 | 2024-06-30 | |
| DEF 14A | 2024-07-22 | 2024-08-05 | |
| 8-K | 2024-07-09 | — | |
| 8-K | 2024-06-11 | — |
Showing 1–50 of 150 filings